Evaluation of pan-HER and c-MET inhibitors tested ex vivo in primary HER2-breast cancer cells with hyperactive c-MET and ErbB family signalingL. G. Laing,D. J. Burns,S. Khan,I. A. MacNeil,B. E. Rich,S. M. Kharbush,S. M. Soltani,B. F. SullivanCANCER RESEARCH(2019)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要